Rentokil Initial PLC

Director's Dealing • Oct 31, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8679R

Rentokil Initial PLC

31 October 2019

Rentokil Initial plc (the Company)

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daragh Fagan

2

Reason for the notification

a)

Position/status

Group General Counsel & Company Secretary

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rentokil Initial plc

b)

LEI

549300VN4WV7Z6T14K68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

ISIN: GB00B082RF11

b)

Nature of the transaction

Sale of shares.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
455.00356	15,000
454.854	5,000
456.6	10,000
456.1011	10,000
456.4	10,000
456.95724	5,000
458.21884	10,000
458.5	5,000
458.00062	5,000
458.01278	5,000
458.6	10,000
458.537607	10,000

d)

Aggregated information

- Aggregated volume

- Aggregated price

100,000

457.209458p

e)

Date of the transaction

31 October 2019

f)

Place of the transaction

London Stock Exchange (XLON)

Enquiries:

Catherine Stead, Deputy Company Secretary              Rentokil Initial plc             01276 607444

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBUBDGDUXBGCB